Eventide Asset Management – KALVISTA PHARMACEUTICALS INC

Eventide Asset Management ownership history of KALVISTA PHARMACEUTICALS INC
QuarterValueSharesWeighting
Q1 2021$35,272
10.6%
1,373,000
-18.3%
0.52%
7.0%
Q4 2020$31,903
50.8%
1,680,0000.0%0.49%
18.1%
Q3 2020$21,151
4.0%
1,680,0000.0%0.41%
-6.3%
Q2 2020$20,328
58.2%
1,680,0000.0%0.44%
6.2%
Q1 2020$12,852
-57.0%
1,680,0000.0%0.42%
-50.7%
Q4 2019$29,921
53.5%
1,680,0000.0%0.84%
30.9%
Q3 2019$19,488
-41.3%
1,680,000
12.0%
0.64%
-36.2%
Q2 2019$33,225
29.0%
1,500,000
66.7%
1.01%
14.0%
Q1 2019$25,758
44.9%
900,0000.0%0.89%
12.6%
Q4 2018$17,775
-10.7%
900,0000.0%0.79%
7.7%
Q3 2018$19,899
172.3%
900,0000.0%0.73%
141.3%
Q2 2018$7,308
-14.3%
900,0000.0%0.30%
-24.1%
Q1 2018$8,532
23.4%
900,000
26.9%
0.40%
10.8%
Q4 2017$6,913
162.2%
709,000
79.0%
0.36%
141.6%
Q3 2017$2,637
92.9%
396,000
108.5%
0.15%
75.3%
Q2 2017$1,367
78.5%
189,900
93.6%
0.08%
66.7%
Q1 2017$76698,1000.05%